wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q48582947-15E325FB-314F-4DE6-8FBD-762301BBD64C
Q48582947-15E325FB-314F-4DE6-8FBD-762301BBD64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48582947-15E325FB-314F-4DE6-8FBD-762301BBD64C
Surotomycin versus vancomycin in adults with Clostridium difficile infection: primary clinical outcomes from the second pivotal, randomized, double-blind, Phase 3 trial.
P2860
Q48582947-15E325FB-314F-4DE6-8FBD-762301BBD64C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48582947-15E325FB-314F-4DE6-8FBD-762301BBD64C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09cfc4d677a3288fb7196679685a9c12cdd01a0e
P2860
Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI.